Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clin Exp Rheumatol. 2022 May;40(4):765-771. doi: 10.55563/clinexprheumatol/mbs830. Epub 2022 Jan 27.
This study aimed to investigate the clinical characteristics, results, and prognostic predictors of patients with Takayasu's arteritis (TAK) along with pulmonary artery involvement (PAI).
A total of 806 patients with TAK admitted to the Fuwai Hospital were screened. Clinical symptoms, imaging features, and prognosis were analysed, and patients were categorised into those with and those without pulmonary hypertension (PH). Additionally, risk factors associated with cardiac death and repeated hospitalisation were explored.
Among 806 patients with TAK, 142 patients with PAI were included, 90.8% (n=129) of whom had PH diagnosed by right heart catheterisation and 9.2% (n=13) of whom did not. The median follow-up time was 54 (range, 29-83) months. Sixteen patients died from right heart failure caused by PH. Patients with PH were significantly more likely to have worse outcomes than patients without PH (p=0.027). The multivariate Cox proportional regression hazard model showed that the 6-min walk distance (6MWD) and PH-targeted therapy were independent prognostic predictors of cardiac death and hospital readmissions.
This study found that that a significant proportion of patients with TAK along with PAI had PH. Patients with PH had worse prognosis than those without. Further 6MWD and PH-targeted therapy were independent prognostic predictors of cardiac death or repeated hospitalization. In the future, multi-centre clinical studies are needed to further prospectively clarify this issue.
本研究旨在探讨伴有肺动脉受累(PAI)的多发性大动脉炎(TAK)患者的临床特征、转归和预后预测因素。
共筛选了 806 例入组阜外医院的 TAK 患者。分析了临床症状、影像学特征和预后,并将患者分为肺动脉高压(PH)组和非 PH 组。此外,还探讨了与心脏死亡和再次住院相关的危险因素。
在 806 例 TAK 患者中,纳入了 142 例伴有 PAI 的患者,其中 90.8%(n=129)经右心导管检查诊断为 PH,9.2%(n=13)未诊断为 PH。中位随访时间为 54(29-83)个月。16 例患者因 PH 导致右心衰竭死亡。PH 组患者的预后明显差于非 PH 组(p=0.027)。多因素 Cox 比例风险回归模型显示,6 分钟步行距离(6MWD)和 PH 靶向治疗是心脏死亡和再次住院的独立预后预测因素。
本研究发现,相当一部分伴有 PAI 的 TAK 患者存在 PH。PH 患者的预后明显差于无 PH 患者。进一步的 6MWD 和 PH 靶向治疗是心脏死亡或再次住院的独立预后预测因素。未来需要多中心临床研究进一步前瞻性地阐明这一问题。